NeuroSense Therapeutics (NRSN) Retained Earnings (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Retained Earnings came in at -$47.8 million in Q4 2025, down 30.35% year-over-year from -$68.6 million in Q4 2024, and down 15.51% quarter-over-quarter from -$41.4 million in Q2 2025.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Retained Earnings (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Retained Earnings across 6 years of filings, most recently posting -$47.8 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 30.35% year-over-year to -$47.8 million; the TTM figure through Dec 2025 stood at -$47.8 million (down 30.35% YoY), while the FY2025 annual figure was -$47.8 million, down 30.35% from the prior year.
- Retained Earnings came in at -$47.8 million for Q4 2025 at NeuroSense Therapeutics, down from -$41.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$8.4 million in Q4 2021 to a low of -$47.8 million in Q4 2025.
- Average Retained Earnings over 5 years is -$26.8 million, with a median of -$29.1 million recorded in 2023.
- Year-over-year, Retained Earnings tumbled 121.08% in 2023 and slipped 8.3% in 2024.
- Over 5 years, Retained Earnings stood at -$8.4 million in 2021, then tumbled by 89.6% to -$16.0 million in 2022, then sank by 63.11% to -$26.1 million in 2023, then plunged by 40.35% to -$36.7 million in 2024, then sank by 30.35% to -$47.8 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were -$47.8 million in Q4 2025, -$41.4 million in Q2 2025, and -$36.7 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | -22.28 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 9.53 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 15.69 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 37.62 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 5.10 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 558.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | -6.33 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 20.97 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 5.13 Bn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | -47.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -47.79 Mn |
| Jun 30, 2025 | -41.37 Mn |
| Dec 31, 2024 | -36.66 Mn |
| Sep 30, 2024 | -34.53 Mn |
| Jun 30, 2024 | -32.38 Mn |
| Mar 31, 2024 | -31.53 Mn |
| Dec 31, 2023 | -26.12 Mn |
| Sep 30, 2023 | -29.12 Mn |
| Jun 30, 2023 | -29.90 Mn |
| Mar 31, 2023 | -24.68 Mn |
| Dec 31, 2022 | -16.01 Mn |
| Sep 30, 2022 | -17.64 Mn |
| Jun 30, 2022 | -14.64 Mn |
| Mar 31, 2022 | -11.16 Mn |
| Dec 31, 2021 | -8.45 Mn |
| Dec 31, 2020 | -4.41 Mn |
API Access
NeuroSense Therapeutics Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();